Next Article in Journal
Exercise and Occupational Stress among Firefighters
Next Article in Special Issue
Self-Reported Gum Bleeding, Perception, Knowledge, and Behavior in Working-Age Hong Kong Chinese—A Cross-Sectional Study
Previous Article in Journal
The Relationship between Social Support and Secondary Posttraumatic Growth among Health Care Providers Working with Trauma Victims—The Mediating Role of Cognitive Processing
Previous Article in Special Issue
The Relationship between Dental Fear and Anxiety, General Anxiety/Fear, Sensory Over-Responsivity, and Oral Health Behaviors and Outcomes: A Conceptual Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms

1
Precision Medicine Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
2
Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
3
Department of Dental Hygiene, Konyang University, Daejeon 35365, Korea
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(9), 4984; https://doi.org/10.3390/ijerph19094984
Submission received: 9 March 2022 / Revised: 14 April 2022 / Accepted: 18 April 2022 / Published: 20 April 2022
(This article belongs to the Special Issue Approach to Promoting Oral Health)

Abstract

:
Mulberry leaves extract (Morus alba extracts; MAE) is known to have therapeutic potentials for numerous human diseases, including diabetes, neurological disorders, cardiovascular diseases, and cancers. However, there has not been sufficient research proving therapeutic effects on oral disease and its related oral risk factors. Thus, we investigated whether MAE has any anti-inflammatory and anti-bacterial effects on risk factors causing oral infectious diseases. To examine the anti-inflammatory response and bacterial inhibition of MAE, we measured intracellular reactive oxygen species (ROS) generation, production of pro-inflammatory cytokines, and the bacterial growth rate. Our study showed that MAE has anti-inflammatory activities, which inhibit the ROS generation and suppressed the production of pro-inflammatory cytokines (TNF-α and IL-6) in human monocyte THP-1 cells by stimulating lipopolysaccharide (LPS) and/or F. nucleatum, which are the virulent factors in periodontal diseases. Furthermore, MAE inhibited the bacterial growth on oral microorganisms (F. nucleatum and S. mutans) infected THP-1 cells. These findings suggested that MAE could be a potential natural source for therapeutic drugs in oral infectious disease.

1. Introduction

Over 700 species of microorganisms have been identified to exist in the oral cavity of healthy humans, and imbalance of host–microbial homeostasis can cause various oral diseases such as gingivitis, periodontitis, caries, and endodontic infections, and, in addition, further infectious diseases in various distant organ sites [1]. Among them, Fusobacteria nucleatum is a Gram-negative anaerobic bacillus and frequently isolated from both supra- and sub-gingival dental plaque [2]. It is pivotal in facilitating the structural bridge role in developing dental plaque and periodontal diseases, coaggregating with primary colonizers, including Streptococcus oralis, Streptococcus sanguinis, and Streptococcus mitis, etc., and anaerobic secondary colonizers (periodontitis-related keystone species) such as Porphorymonas gingivalis and Aggregatibacter actinomycetemcomitans [2,3]. Additionally, Streptococcus species are predominant in all oral niches. Out of them, S. mutans, a Gram-positive oral bacterium, has long been known to be the main pathogen of dental caries [4,5].
Natural resources have been used to treat various diseases and enhance human health. Mulberry (Morus alba), which belongs to family Moraceae, is multipurpose agroforestry plant that is native to China and widely distributed in many countries, including Asia, India, Africa, America, and Europe [6]. Mulberry leaves extract (Morus alba extracts; MAE) has various functions such as antitumor, antidiabetic, and anti-inflammatory activities, due to its bioactive compound that is rich in polysaccharides, polyphenols, alkaloids, and flavonoids [7,8]. Among its anti-microbial functions, its effect on some oral microorganisms such as S. mutans and P. gingivalis, has been reported in 2008 and 2015, respectively [9,10]. However, it is insufficient to explain anti-inflammatory and anti-microbial effects of MAE on oral microorganisms. Thus, we attempted to identify anti-bacterial and anti-inflammatory potentials of MAE on oral microorganisms (F. nucleatum and S. mutans), which are typical periodontitis and dental caries-related microorganisms, respectively. Additionally, we also examined the anti-inflammatory potentials of MAE in oral keratinocytes and fibroblasts.

2. Materials and Methods

2.1. Preparation of Extracts

The mulberry leaf power (100%) was used for the research material and commercially purchased from Handsherb company (Yeoncheon-si, Korea). The mulberry leaf powder (60 g) and ethanol (600 mL) were mixed and left alone for 24 h at room temperature. Then, only the liquid component excluding precipitates was made to pass through a vacuum filter. Then, we concentrated the filtered extract using a decompression concentrator. The concentrated extract was stored to be analyzed after lyophilization.

2.2. Used Microorganisms and Culture

Streptococuus mutans KCTC 3065 was acquired from the Korean Collection for Type Culture (KCTC) and cultured in the Brain Heart Infusion (BHI) liquid media at 37 °C. Fusobacterium nucleatum ATCC 25586 was purchased from American Type Culture Collection (Manassas, VA, USA) and cultured in the BHI liquid media at 37 °C under the anaerobic condition.
Optical density (OD) of bacteria cultures was measured using the plate reader (BioTek Instruments, Inc., Winooski, VT, USA), with 0.5 and 0.6 OD representing ~109 CFU/mL for S. mutans and F. nucleatum, respectively.

2.3. Cell Culture

THP-1 cells, human monocytic cell lines, were acquired from the Korea Cell Bank (Seoul, Korea) and cultured in RPMI 1640 media with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 0.1 mg/mL streptomycin at 37 °C maintaining 5% CO2 condition. The tests were performed after seeding the cells onto 48-well plates (2 × 104 cells/well) or 6-well plates (2 × 105 cells/well).
Immortalized human oral keratinocytes (IHOKs) [11] and gingival fibroblast (hTERT-hNOFs) [12] were provided by the department of the Oral Pathology in Yonsei University College of Dentistry. IHOK cells were immortalized by HPV16 E6/E7, and hTERT-hNOFs were immortalized by transfection with hTERT to be used in vitro. Both IHOKs and hTERT-hNOFs cells were cultured in DMEM/F12 media (3:1 ratio) with 10% FBS and 1% penicillin/streptomycin at 37 °C maintaining 5% CO2 condition.

2.4. Cell Viability Test

The effect of MAE on THP-1 cell viability (>80% confluence of plates) was determined using a colorimetric EZ-CyTox Kit (Deaillab Service Co., Seoul, Korea) according to the manufacturer’s instructions. The absorbance was measured at 450 nm using a plate reader (BioTek Instruments, Inc., Winooski, VT, USA).
IHOKs and hTERT-hNOFs were seeded onto 96-well plates by 1 × 104 and treated with MAE with serum-free media (DMEM/F12 media (3:1 ratio)) for 24 h. Cell viability was measured by MTT (Duchefa, Haarlem, The Netherlands) assay. In brief, MTT solution was added and incubated at 37 °C for 4 h. After incubation, DMSO (MTT solvent) was added into each cell. The absorbance was read at 590 nm by using a microplate reader. All experiments were performed in triplicate.

2.5. Flow Cytometry

To check the generation of reactive oxygen species (ROS), THP-1 cells were seeded onto 6-well plates (2 × 105 cells/well). The cells were pretreated with MAE by changing concentration levels for 2 h and stimulated by LPS (InvivoGen, San Diego, CA, USA) for 24 h. The stimulated cells were washed with PBS and dyed with DCFDA (Abcam, Cambridge, MA, USA) for 30 min. Living cells (10,000 cells) were screened based on their forward- and side-scatter profiles. The samples were collected using BD FACSCalibur Flow Cytometer (BD Biosciences, San Jose, CA, USA) and the data were analyzed by BD CellQuest Pro Software (BD Biosciences, San Jose, CA, USA).
IHOKs (5 × 105 cells/well) and hTERT-hNOFs (4 × 105 cells/well) were seeded in the 6-well plate and pre-treated with the MAE using different concentrations (5, 10, and 20 mg/mL) for 1 h, and applied with 10 ng/mL LPS for 24 h. Next, fluorescent probe 2′7′-dichlorofluorescin diacetate (H2DCFDA) dye (Molecular Probes, Eugene, OR, USA) was used. According to instruction, both cells were applied with 10 μM of H2DCFDA dye in the dark at 37 °C for 20 min. ROS were analyzed by flow cytometry (Becton Dickinson, Beckman coulter).

2.6. Enzyme-Linked Immunosorbent Assay (ELISA)

THP-1 cells were pretreated with MAE for 2 h and then applied with LPS and F. nucleatum for 24 h. Cell culture supernatants were collected, and IL-6 and TNF-α were measured using the commercial ELISA kit (R&D Systems, Minneapolis, MN, USA).

2.7. Bacterial Growth

MAE (20, 40, and 80 mg/mL) was added to the BHI liquid media in the test group while no MAE was added in the control group. S. mutans and F. nucleatum (1 × 107 bacteria) were inoculated and cultured in each media, then absorbance was measured using the optical density. Mean values were calculated by testing three times to gain the repeatable results in all test groups.

2.8. Statistical Analysis

The differences among the mean values of different groups were assessed. Data is expressed as the mean ± standard deviation. Statistical significance tests were performed using one-way analysis of variance followed by the Tukey post-hoc test using GraphPad Prism version 5.00 (GraphPad Software, Inc., La Jolla, CA, USA). p < 0.05 was determined to indicate a statistical significance.

3. Results

3.1. MAE Decreased the Production of ROS in LPS-Stimulated THP-1 and Oral Cells

To investigate the effects of MAE on cell viability, WST analysis was performed in THP-1 after treatment of MAE by various concentrations (10–80 mg/mL). Cells did not show significant cytotoxicity in the range of 10–40 mg/mL of MAE while the cell viability declined when the cells were treated with 80 mg/mL of MAE (Figure 1).
Hence, MAE was used with 10, 20, and 40 mg/mL which proved to be non-cytotoxic. Next, we performed flow cytometry analysis to investigate whether MAE inhibits the increase in ROS by treatment with lipopolysaccharide (LPS), which is the richest component in the cell wall of Gram-negative germs. Results showed that LPS-induced ROS production was decreased in a dose-dependent manner when cells were pretreated with 10–40 mg/mL of MAE (Figure 2).
In addition, we examined the effects of MAE in inflamed oral cells. Oral keratinocytes (IHOK) and fibroblasts (hTERT-hNOFs) were used to measure ROS generation in oral cells with MAE treatment. First, the MTT assay was performed to check the cytotoxicity of MAE. The cell viability was significantly reduced in IHOK with the treatment of 5, 10, 20, and 40 mg/mL of MAE. Meanwhile, the cell viability of hTERT-hNOFs declined significantly only when the cells were treated with 40 mg/mL of MAE (Figure S1). To perform the following test, the concentration levels of MAE were selected showing weak (within 80–60% of cell viability) or non-cytotoxicity (>80% of cell viability) in IHOKs and hTERT-hNOFs, respectively. Although ROS increased due to the inflammatory effect from LPS induction, MAE induced a decline in ROS by 3.8–4.8 times in LPS-stimulated IHOKs (Figure S2) and by 1.3–2.5 times in LPS-stimulated hTERT-hNOFs (Figure S3).
Collectively, MAE could reduce ROS generation increased by LPS, indicating that MAE functions as an antioxidant in oral cells as well as monocytes.

3.2. MAE Decreased the Generation of IL-6 and TNF-α in LPS/F. nucleatum-Stimulated THP-1 Cells

Next, we investigated whether MAE regulated production of inflammatory cytokines. First, we identified the effect of MAE in LPS-stimulated THP-1 cells. LPS induces the production of IL-6 and TNF-α, and both cytokines were markedly decreased after pretreatment with MAE in dose-dependent manner (Figure 3A,B). Next, we examined the effect of MAE in THP-1 infected by F. nucleatum, which is a typical germ involved in developing periodontal diseases. Infection of F. nucleatum led to generation of IL-6 and TNF-α and they were inhibited by pretreatment with MAE significantly (Figure 3C,D).
Collectively, MAE could effectively reduce generation of pro-inflammatory cytokines in THP-1 cells stimulated by LPS and F. nucleatum.

3.3. MAE Has Antibiotic Effects against F. nucleatum and S. mutans

Last, we investigated whether MAE showed the antibiotic effects against F. nucleatum and S. mutans, which is known to be a pathogen causing periodontal diseases and dental caries, respectively. After completing culture of F. nucleatum in BHI liquid media with different concentration levels of MAE, absorbance was measured using the plate reader. We confirmed that bacterial growth was significantly declined in F. nucleatum with MAE more than F. nucleatum without MAE (Figure 4). Consistently, the growth of S. mutans declined in a dose-dependent manner of MAE. Therefore, anti-bacterial effects of MAE were confirmed against oral bacteria, such as F. nucleatum and S. mutans.

4. Discussion

Natural sources have been known to work as complementary and alternative medicines for centuries, with low levels of toxicity, therapeutic properties, and effects [13,14]. In contrast, some natural sources well known in traditional medicine have demonstrated that they have various toxicities [15]. However, Morus alba called mulberry has been evaluated as a safe herb showing no side effects [16,17]. The fruits, leaves, branches, and roots of mulberry possess a range of biological treatment effects on numerous human diseases [18,19], including diabetes, neurological disorders, cardiovascular diseases, and cancers [20,21,22,23,24]. However, there has not been sufficient research proving that mulberry can function as a therapeutic agent in oral diseases and its related oral risk factors.
Inflammation is the process of recognizing and eliminating various harmful stimuli and initiating the healing process [25]. Pathogen infection can induce an inflammatory response through activation of pattern-recognition receptors (PRRs) [25,26]. The identification of PRRs by pathogens is mediated by various tissue-resident immune cells, leading to the release of inflammatory mediators, including chemokines and cytokines [27,28]. In addition, the antioxidant defense system affects oxidative stress. Increased oxidative stress can induce production of reactive oxygen species (ROS), which activate various transcription factors, including NF-κB, AP-1, p53, and STAT, followed by increased growth factors, inflammatory cytokines, and chemokines [29]. Based on such a background, we investigated inflammatory responses such as cytokines and ROS to identify the anti-inflammatory and anti-bacterial potentials of MAE.
Monocytes and macrophages are critical cell types which recognize foreign pathogens using PRRs, and they secrete various pro-inflammatory chemokines and cytokines [30,31]. Thus, we mainly used THP-1 cell lines, which have been well known as human monocytes and macrophages in studies of inflammatory disease in vitro [31]. We applied LPS to induce inflammation in THP-1 cells because a key player in general bacteria-derived inflammation is LPS, also referred to as endotoxin [32,33]. First, we observed the effect of MAE as antioxidants in LPS-stimulated cells. MAE inhibited the increase in intracellular ROS production in LPS-stimulated THP-1 cells. Some researchers have consistently reported that MAE inhibits oxidative stress [34,35]. It means that MAE functions as an antioxidant in various cell types. However, there are few studies proving antioxidant effects of MAE in oral cells; there have been some studies showing anti-inflammatory effects in periodontal ligament cells (PDLs) [36,37]. Given that, we additionally examined ROS generation in oral cells. We selected two types of oral cells composed of oral mucosa; oral keratinocytes (immortalized human oral keratinocytes; IHOKs) [11] and fibroblasts (hTERT-transfected human normal oral fibroblasts; hTERT-hNOFs) [12]. Both cells were immortalized cell lines to use in vitro by transfecting HPV16 E6/E7 and hTERT, respectively. It was shown that LPS-stimulated IHOK and hTERT-hNOFs increased intracellular ROS, and then it was decreased by MAE. Thus, our findings suggested that MAE could function as antioxidants in oral inflammation.
Periodontitis and caries are the major oral diseases, in relation to oral microbiota [38]. It is now well-established that S. mutans are associated with initiation of dental caries by acid production, sugar fermentation, and acid tolerance [4,39]. Periodontitis is an infectious and inflammatory disease characterized by progressive infiltration of bacteria and inflammatory cytokines into periodontal tissues, resulting in attachment loss, alveolar bone destruction, and the loss of teeth [40,41]. Among prime periodontal disease-related bacteria, P. gingivalis, Gram-negative, and anaerobic bacteria, are one of major causative pathogens which are found in > 85% of subgingival plaque of periodontitis patients [42]. Especially, P. gingivalis-LPS is a strong virulence factor in periodontitis and induces cytokine secretion (TNF-α, IL-6, and MCP-1) and inflammatory responses via TLRs [43]. The results of our study are consistent to various other research showing anti-inflammatory effects of MAE in P. gingivalis-infected THP-1 cells [44]. In addition to P. gingivalis, F. nucleatum is another key-stone periodontal pathogen. In dental plaque, F. nucleatum plays a structurally supportive and interconnecting role between commensal early colonizers and more pathogenic late colonizers, indicating that F. nucleatum acts as a backbone in progression of periodontal diseases [2]. Hence, we focused on F. nucleatum as the main causative bacteria of periodontitis more than P. gingivalis. To mimic the inflammatory response in periodontal tissues, we applied with LPS and F. nucleatum, the main causative factors in periodontal diseases. Our study showed that LPS-induced TNF-α and IL-6 were reduced by MAE in THP-1 cells. Additionally, F. nucleatum-infected THP-1 cells showed the increase in TNF-α and IL-6 and they were downregulated by MAE. Collectively, MAE was found to block the secretion of pro-inflammatory cytokines increased by stimulation of various periodontal pathogens, indicating that MAE might have potential for developing therapeutic herbal medicines in periodontal diseases. Even F. nucleatum can have a pathogenic role in extra-oral diseases such as colorectal cancer, inflammatory bowel disease, and rheumatoid arthritis [45,46,47]. Thus, MAE might be effective herbs in various human diseases caused by F. nucleatum, as well as periodontal disease. Lastly, we observed the effect of MAE in inhibiting bacterial growth. We selected two typical oral disease-related bacteria (S. mutans and F. nucleatum) and found that the growth of both bacteria was inhibited by MAE, varying in different doses. Our results are consistent with other studies showing that MAE have anti-inflammatory and anti-bacterial effects on oral bacteria. For example, the component (1-deoxynojirimycin (DNJ)) of MAE showed anti-adhesive effects by controlling the overgrowth and inhibiting biofilm formation of S. mutans [9]. Additionally, MAE have anti-inflammatory effects by suppressing MMPs, tissue destruction-related protein, in P. gingivalis LPS-infected THP-1 cells [44]. Taken together, MAE could function as anti-bacterial and anti-inflammatory agents in oral microorganisms.
We demonstrated the anti-inflammatory and anti-bacterial effects of MAE on risk factors causing oral infectious diseases. However, there are some limitations of this study. THP-1 cells were used to investigate the anti-inflammatory response of MAE, while oral cells were only used to identify the antioxidant effects. However, one study has verified that LPS increases inflammatory cytokines such as IL-1β, IL-6, and IL-8 in hTERT-hNOFs and IHOKs which our study used [48]. Additionally, we need to further study whether F. nucleatum can increase cytokines, similar to results by LPS. Additionally, we did not observe the anti-inflammatory and anti-oxidant mechanisms of MAE in THP-1 cells, but only observed the anti-inflammatory phenomenon. Our findings are consistent with some other studies showing that IL-6 and TNF-α were increased by LPS in macrophages [49,50]. The inflammatory response can be orchestrated by pro-inflammatory cytokines such as TNF-α and IL-6 [25,51,52] and it can be mediated through NF-κB transcriptional factor [44,52]. Additionally, ROS can be regulated by NF-kB [53]. Based on other studies, we can speculate that anti-inflammatory signals of MAE might be involved in NF-kB-mediated signaling pathways [41]. Additionally, we need to identify what components of MAE can trigger anti-inflammatory and anti-bacterial effects. Phytochemical studies have revealed that MAE have many bioactive constituents, including flavonoids, cumarins, phenolic acid, alkaloids, and terpenoids [8]. In particular, flavonoids and phenolic acid in MAE have functions as antioxidants and anti-bacterial effects [18,19]. Considering that, we also speculate that flavonoids and/or phenolic acid might inhibit the ROS generation and production of pro-inflammatory cytokines in MAE. To solve these limitations, further studies are needed to clarify what components of MAE are considered in anti-inflammatory functions and their mechanism in detail.

5. Conclusions

In conclusion, we demonstrated that MAE has anti-inflammatory effects, which can inhibit ROS generation and suppress production of pro-inflammatory cytokines in human monocyte THP-1 cells by stimulating LPS and/or F. nucleatum. Furthermore, MAE can inhibit the bacterial growth in oral microbes F. nucleatum and S. mutans. These findings suggested that MAE could be a potential natural source for prophylactic and therapeutic agents in oral infectious disease.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijerph19094984/s1, Figure S1: The cytotoxicity test by MAE in oral keratinocytes and fibroblasts; Figure S2: ROS generation by MAE in oral keratinocytes; Figure S3: ROS generation by MAE in oral fibroblasts.

Author Contributions

Conceptualization, D.K. and K.-H.K.; methodology, D.K. and K.-H.K.; validation, D.K. and K.-H.K.; formal analysis, K.-H.K.; investigation, D.K. and K.-H.K.; resources, K.-H.K.; data curation, D.K. and K.-H.K.; writing—original draft preparation, D.K.; writing—review and editing, K.-H.K.; visualization, K.-H.K.; supervision, K.-H.K.; funding acquisition, K.-H.K. All authors have read and agreed to the published version of the manuscript.

Funding

This paper was supported by the Konyang University Research Fund in 2020 and the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Education) (No. NRF-2017R1D1A1B03035544).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable. The cell lines used in this study are not required ethics approval for their use.

Data Availability Statement

All data are available on request from the corresponding author.

Acknowledgments

All authors have read and consent to publish this manuscript, and we thank all participants in the study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dewhirst, F.E.; Chen, T.; Izard, J.; Paster, B.J.; Tanner, A.C.R.; Yu, W.-H.; Lakshmanan, A.; Wade, W.G. The Human Oral Microbiome. J. Bacteriol. 2010, 192, 5002–5017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Brennan, C.A.; Garrett, W.S. Fusobacterium nucleatum—Symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 2019, 17, 156–166. [Google Scholar] [CrossRef] [PubMed]
  3. Kolenbrander, P.E.; Palmer, R.J., Jr.; Periasamy, S.; Jakubovics, N.S. Oral multispecies biofilm development and the key role of cell–cell distance. Nat. Rev. Microbiol. 2010, 8, 471–480. [Google Scholar] [CrossRef] [PubMed]
  4. Loesche, W.J. Role of streptococcus mutans in human dental decay. Microbiol. Rev. 1986, 50, 353–380. [Google Scholar] [CrossRef]
  5. Smith, E.G.; Spatafora, G.A. Gene regulation in s. Mutans: Complex control in a complex environment. J. Dent. Res. 2012, 91, 133–141. [Google Scholar] [CrossRef]
  6. Zhang, H.; Ma, Z.F.; Luo, X.; Li, X. Effects of Mulberry Fruit (Morus alba L.) Consumption on Health Outcomes: A Mini-Review. Antioxidants 2018, 7, 69. [Google Scholar] [CrossRef] [Green Version]
  7. Liu, Z.Z.; Liu, Q.H.; Liu, Z.; Tang, J.W.; Chua, E.G.; Li, F.; Xiong, X.S.; Wang, M.M.; Wen, P.B.; Shi, X.Y.; et al. Ethanol extract of mulberry leaves partially restores the composition of intestinal microbiota and strengthens liver glycogen fragility in type 2 diabetic rats. BMC Complement. Med. Ther. 2021, 21, 172. [Google Scholar] [CrossRef]
  8. Chan, E.W.C.; Lye, P.-Y.; Wong, S.-K. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin. J. Nat. Med. 2016, 14, 17–30. [Google Scholar] [CrossRef]
  9. Islam, B.; Khan, S.N.; Haque, I.; Alam, M.; Mushfiq, M.; Khan, A.U. Novel anti-adherence activity of mulberry leaves: Inhibition of Streptococcus mutans biofilm by 1-deoxynojirimycin isolated from Morus alba. J. Antimicrob. Chemother. 2008, 62, 751–757. [Google Scholar] [CrossRef] [Green Version]
  10. Gunjal, S.; Ankola, A.V.; Bhat, K. In vitro antibacterial activity of ethanolic extract of Morus alba leaf against periodontal pathogens. Indian J. Dent. Res. 2015, 26, 533–536. [Google Scholar] [CrossRef]
  11. Lee, H.-J.; Guo, H.-Y.; Lee, S.-K.; Jeon, B.-H.; Jun, C.-D.; Lee, S.-K.; Park, M.-H.; Kim, E.-C. Effects of nicotine on proliferation, cell cycle, and differentiation in immortalized and malignant oral keratinocytes. J. Oral Pathol. Med. 2005, 34, 436–443. [Google Scholar] [CrossRef] [PubMed]
  12. Illeperuma, R.P.; Park, Y.J.; Kim, J.M.; Bae, J.Y.; Che, Z.M.; Son, H.K.; Han, M.R.; Kim, K.-M.; Kim, J. Immortalized gingival fibroblasts as a cytotoxicity test model for dental materials. J. Mater. Sci. Mater. Med. 2012, 23, 753–762. [Google Scholar] [CrossRef] [PubMed]
  13. Mathur, S.; Hoskins, C. Drug development: Lessons from nature. Biomed. Rep. 2017, 6, 612–614. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M.; International Natural Product Sciences Taskforce; Supuran, C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216. [Google Scholar] [CrossRef]
  15. Poppenga, R.H. Herbal medicine: Potential for intoxication and interactions with conventional drugs. Clin. Tech. Small Anim. Pract. 2002, 17, 6–18. [Google Scholar] [CrossRef]
  16. Li, Y.; Zhang, X.; Liang, C.; Hu, J.; Yu, Z. Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies. Regul. Toxicol. Pharmacol. 2018, 95, 220–226. [Google Scholar] [CrossRef]
  17. Hong, M.; Lu, M.; Qian, Y.; Wei, L.; Zhang, Y.; Pan, X.; Li, H.; Chen, H.; Tang, N. A 90-day Sub-chronic Oral Toxicity Assessment of Mulberry Extract in Sprague Dawley Rats. Inq. J. Health Care Organ. Provis. Financ. 2021, 58, 469580211056044. [Google Scholar] [CrossRef]
  18. Sohn, H.-Y.; Son, K.; Kwon, C.-S.; Kang, S. Antimicrobial and cytotoxic activity of 18 prenylated flavonoids isolated from medicinal plants: Morus alba L., Morus mongolica Schneider, Broussnetia papyrifera (L.) Vent, Sophora flavescens Ait and Echinosophora koreensis Nakai. Phytomedicine 2004, 11, 666–672. [Google Scholar] [CrossRef]
  19. Yuan, Q.; Zhao, L. The mulberry (Morus alba L.) fruit—A review of characteristic components and health benefits. J. Agric. Food Chem. 2017, 65, 10383–10394. [Google Scholar] [CrossRef]
  20. Chan, K.-C.; Yang, M.-Y.; Lin, M.-C.; Lee, Y.-J.; Chang, W.-C.; Wang, C.-J. Mulberry Leaf Extract Inhibits the Development of Atherosclerosis in Cholesterol-Fed Rabbits and in Cultured Aortic Vascular Smooth Muscle Cells. J. Agric. Food Chem. 2013, 61, 2780–2788. [Google Scholar] [CrossRef]
  21. Meng, Q.; Qi, X.; Fu, Y.; Chen, Q.; Cheng, P.; Yu, X.; Sun, X.; Wu, J.; Li, W.; Zhang, Q.; et al. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes. J. Ethnopharmacol. 2020, 248, 112326. [Google Scholar] [CrossRef] [PubMed]
  22. Tam, D.N.H.; Nam, N.H.; Elhady, M.T.; Tran, L.; Hassan, O.G.; Sadik, M.; Tien, P.T.M.; Elshafei, G.A.; Huy, N.T. Effects of Mulberry on The Central Nervous System: A Literature Review. Curr. Neuropharmacol. 2020, 19, 193–219. [Google Scholar] [CrossRef] [PubMed]
  23. Yamamoto, K.; Sakamoto, Y.; Mizowaki, Y.; Iwagaki, Y.; Kimura, T.; Nakagawa, K.; Miyazawa, T.; Tsuduki, T. Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice. J. Clin. Biochem. Nutr. 2017, 61, 47–52. [Google Scholar] [CrossRef] [Green Version]
  24. Park, H.-J.; Min, T.-R.; Chi, G.-Y.; Choi, Y.-H.; Park, S.-H. Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation. Biochem. Biophys. Res. Commun. 2018, 505, 194–200. [Google Scholar] [CrossRef] [PubMed]
  25. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454, 428–435. [Google Scholar] [CrossRef] [PubMed]
  26. Barton, G.M. A calculated response: Control of inflammation by the innate immune system. J. Clin. Investig. 2008, 118, 413–420. [Google Scholar] [CrossRef]
  27. Vijay, K. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int. Immunopharmacol. 2018, 59, 391–412. [Google Scholar] [CrossRef] [PubMed]
  28. Proietto, A.I.; O’Keeffe, M.; Gartlan, K.; Wright, M.D.; Shortman, K.; Wu, L.; Lahoud, M.H. Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 2004, 209, 163–172. [Google Scholar] [CrossRef]
  29. Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxid. Redox Signal. 2014, 20, 1126–1167. [Google Scholar] [CrossRef] [Green Version]
  30. Shi, C.; Pamer, E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11, 762–774. [Google Scholar] [CrossRef] [Green Version]
  31. Chanput, W.; Mes, J.J.; Wichers, H.J. THP-1 cell line: An in vitro cell model for immune modulation approach. Int. Immunopharmacol. 2014, 23, 37–45. [Google Scholar] [CrossRef] [PubMed]
  32. Chanput, W.; Mes, J.; Vreeburg, R.A.M.; Savelkoul, H.F.J.; Wichers, H.J. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: A tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010, 1, 254–261. [Google Scholar] [CrossRef] [PubMed]
  33. Liu, L.; Guo, H.; Song, A.; Huang, J.; Zhang, Y.; Jin, S.; Li, S.; Zhang, L.; Yang, C.; Yang, P. Progranulin inhibits lps-induced macrophage m1 polarization via nf-small ka, cyrillicb and mapk pathways. BMC Immunol. 2020, 21, 32. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, Y.R.; Lee, J.S.; Lee, K.R.; Kim, Y.E.; Baek, N.I.; Hong, E.K. Effects of mulberry ethanol extracts on hydrogen peroxide-induced oxidative stress in pancreatic beta-cells. Int. J. Mol. Med. 2014, 33, 128–134. [Google Scholar] [CrossRef] [Green Version]
  35. Lee, G.-H.; Hoang, T.-H.; Jung, E.-S.; Jung, S.-J.; Chae, S.-W.; Chae, H.-J. Mulberry Extract Attenuates Endothelial Dysfunction through the Regulation of Uncoupling Endothelial Nitric Oxide Synthase in High Fat Diet Rats. Nutrients 2019, 11, 978. [Google Scholar] [CrossRef] [Green Version]
  36. Yiemwattana, I.; Chaisomboon, N.; Jamdee, K. Antibacterial and Anti-inflammatory Potential of Morus alba Stem Extract. Open Dent. J. 2018, 12, 265–274. [Google Scholar] [CrossRef]
  37. Özan, F.; Tepe, B.; Polat, Z.A.; Er, K. Evaluation of in vitro effect of Morus rubra (red mulberry) on survival of periodontal ligament cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2008, 105, e66–e69. [Google Scholar] [CrossRef]
  38. Manji, F.; Dahlén, G.; Fejerskov, O. Caries and Periodontitis: Contesting the Conventional Wisdom on Their Aetiology. Caries Res. 2018, 52, 548–564. [Google Scholar] [CrossRef] [Green Version]
  39. Oliveira, B.E.C.; Filho, A.P.R.; Burne, R.A.; Zeng, L. The Route of Sucrose Utilization by Streptococcus mutans Affects Intracellular Polysaccharide Metabolism. Front. Microbiol. 2021, 12, 33. [Google Scholar] [CrossRef]
  40. Cekici, A.; Kantarci, A.; Hasturk, H.; Van Dyke, T.E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontology 2000 2014, 64, 57–80. [Google Scholar] [CrossRef] [Green Version]
  41. Slots, J. Periodontitis: Facts, fallacies and the future. Periodontology 2000 2017, 75, 7–23. [Google Scholar] [CrossRef] [PubMed]
  42. How, K.Y.; Song, K.P.; Chan, K.G. Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum line. Front. Microbiol. 2016, 7, 53. [Google Scholar] [CrossRef] [PubMed]
  43. Nativel, B.; Couret, D.; Giraud, P.; Meilhac, O.; D’Hellencourt, C.L.; Viranaïcken, W.; Da Silva, C.R. Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human. Sci. Rep. 2017, 7, 15789. [Google Scholar] [CrossRef] [PubMed]
  44. Yiemwattana, I.; Kaomongkolgit, R.; Wirojchanasak, S.; Chaisomboon, N. Morus alba stem extract suppresses matrix metalloproteinases (mmp)-1, mmp-9, and tissue inhibitors of metalloproteinase (timp)-1 expression via inhibition of ikappabalpha degradation induced by porphyromonas gingivalis lps signal in thp-1 cells. Eur. J. Dent. 2019, 13, 229–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Shang, F.M.; Liu, H.L. Fusobacterium nucleatum and colorectal cancer: A review. World J. Gastrointest. Oncol. 2018, 10, 71–81. [Google Scholar] [CrossRef]
  46. Strauss, J.; Kaplan, G.; Beck, P.L.; Rioux, K.; Panaccione, R.; DeVinney, R.; Lynch, T.; Allen-Vercoe, E. Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 2011, 17, 1971–1978. [Google Scholar] [CrossRef]
  47. Thé, J.; Ebersole, J.L. Rheumatoid factor (RF) distribution in periodontal disease. J. Clin. Immunol. 1991, 11, 132–142. [Google Scholar] [CrossRef]
  48. Jeong, W.-S.; Kwon, J.-S.; Choi, E.-H.; Kim, K.-M. The Effects of Non-Thermal Atmospheric Pressure Plasma treated Titanium Surface on Behaviors of Oral Soft Tissue Cells. Sci. Rep. 2018, 8, 15963. [Google Scholar] [CrossRef] [Green Version]
  49. Marton, A.; Kolozsi, C.; Kusz, E.; Olah, Z.; Letoha, T.; Vizler, C.; Pecze, L. Propylene-glycol aggravates LPS-induced sepsis through production of TNF-α and IL-6. Iran. J. Immunol. IJI 2014, 11, 113–122. [Google Scholar]
  50. Song, R.; Kim, J.; Yu, D.; Park, C.; Park, J. Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin. Veter Immunol. Immunopathol. 2012, 146, 143–149. [Google Scholar] [CrossRef]
  51. Montgomery, S.L.; Bowers, W.J. Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System. J. Neuroimmune Pharmacol. 2011, 7, 42–59. [Google Scholar] [CrossRef] [PubMed]
  52. Zelová, H.; Hošek, J. TNF-α signalling and inflammation: Interactions between old acquaintances. Inflamm. Res. 2013, 62, 641–651. [Google Scholar] [CrossRef] [PubMed]
  53. Morgan, M.J.; Liu, Z.G. Crosstalk of reactive oxygen species and nf-kappab signaling. Cell Res. 2011, 21, 103–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The cytotoxicity test of mulberry leaves extract (Morus alba extracts; MAE) in THP-1 cells. The cell viability of THP-1 in various concentration levels of MAE. THP-1 was treated with 10, 20, 40, and 80 mg/mL of MAE for 24 h. Data were analyzed by one-way ANOVA. * p < 0.05.
Figure 1. The cytotoxicity test of mulberry leaves extract (Morus alba extracts; MAE) in THP-1 cells. The cell viability of THP-1 in various concentration levels of MAE. THP-1 was treated with 10, 20, 40, and 80 mg/mL of MAE for 24 h. Data were analyzed by one-way ANOVA. * p < 0.05.
Ijerph 19 04984 g001
Figure 2. MAE reduced generation of reactive oxygen species (ROS) in THP-1 cells stimulated by lipopolysaccharide (LPS). THP-1 was pretreated with MAE for 2 h and stimulated by LPS (100 ng/mL) for 24 h. ROS expression in the cell was shown by flow cytometry using a DCFDA antibody. The data were analyzed using one-way ANOVA. *** p < 0.001.
Figure 2. MAE reduced generation of reactive oxygen species (ROS) in THP-1 cells stimulated by lipopolysaccharide (LPS). THP-1 was pretreated with MAE for 2 h and stimulated by LPS (100 ng/mL) for 24 h. ROS expression in the cell was shown by flow cytometry using a DCFDA antibody. The data were analyzed using one-way ANOVA. *** p < 0.001.
Ijerph 19 04984 g002
Figure 3. The effect of MAE inhibiting generation of cytokines in THP-1 cells stimulated by LPS/F. nucleatum. THP-1 was pretreated with different concentrations of MAE for 2 h and stimulated by either LPS (100 ng/mL) or F. nucleatum (MOI 10) for 24 h. The concentrations of IL-6 (A,C) and TNF-α (B,D) were measured by ELISA in the culture supernatant. The data were analyzed using one-way ANOVA. *** p < 0.001.
Figure 3. The effect of MAE inhibiting generation of cytokines in THP-1 cells stimulated by LPS/F. nucleatum. THP-1 was pretreated with different concentrations of MAE for 2 h and stimulated by either LPS (100 ng/mL) or F. nucleatum (MOI 10) for 24 h. The concentrations of IL-6 (A,C) and TNF-α (B,D) were measured by ELISA in the culture supernatant. The data were analyzed using one-way ANOVA. *** p < 0.001.
Ijerph 19 04984 g003
Figure 4. The effect of MAE in inhibiting growth of both F. nucleatum and S. mutans. MAE (0, 20, 40, and 80 mg/mL) was added in BHI liquid media, F. nucleatem (A) was inoculated (1 × 107 bacteria), and it was cultured for 24 h. S. mutans (B) was inoculated (1 × 107 bacteria) and it was cultured for 12 h. The absorbance was measured by optical density. The data were analyzed using a one-way ANOVA. ** p < 0.01, *** p < 0.001.
Figure 4. The effect of MAE in inhibiting growth of both F. nucleatum and S. mutans. MAE (0, 20, 40, and 80 mg/mL) was added in BHI liquid media, F. nucleatem (A) was inoculated (1 × 107 bacteria), and it was cultured for 24 h. S. mutans (B) was inoculated (1 × 107 bacteria) and it was cultured for 12 h. The absorbance was measured by optical density. The data were analyzed using a one-way ANOVA. ** p < 0.01, *** p < 0.001.
Ijerph 19 04984 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kim, D.; Kang, K.-H. Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms. Int. J. Environ. Res. Public Health 2022, 19, 4984. https://doi.org/10.3390/ijerph19094984

AMA Style

Kim D, Kang K-H. Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms. International Journal of Environmental Research and Public Health. 2022; 19(9):4984. https://doi.org/10.3390/ijerph19094984

Chicago/Turabian Style

Kim, Dokyeong, and Kyung-Hee Kang. 2022. "Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms" International Journal of Environmental Research and Public Health 19, no. 9: 4984. https://doi.org/10.3390/ijerph19094984

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop